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The purpose of this case study was to observe the effects of a rehabilitation program with an audio-biofeedback technology device called
Electroskip in a patient with Parkinson disease. The patient was a
61-year-old man with moderate Parkinson disease (Hoehn and Yahr
Parkinson’s scale stage III) and dementia who had progressive episodes of freezing of gait. The patient also had a history of recent falls.
The patient completed a 6-week rehabilitation program focused on
functional tasks, balance and gait training while using Electroskip technology, which is a wireless, wearable device that sends a discrete real-time generative audio-biofeedback signal when the user steps on either the heel or toe force sensors positioned under the innersoles. The
outcome measures included the Timed Up and Go test, the modified
Gait Abnormality Rating Scale, the modified Parkinson’s Activity Scale,

and the Freezing of Gait Questionnaire. The patient completed 17 of the
18 scheduled training sessions and all testing sessions; no adverse
events occurred during the rehabilitation program and high satisfaction
levels were reported by the patient and family after completion of the
6-week rehabilitation program. Clinically significant improvements were
seen in all measures at 6 weeks. The results of this report suggest that
a rehabilitation program focused on functional tasks, balance, and gait
training using the Electroskip technology may be beneficial for improving gait and balance in a patient with moderate Parkinson disease. Future work is needed to determine the effectiveness of Electroskip technology by means of randomized controlled trials.
Keywords: Parkinson disease, Physical therapy, Electroskip

INTRODUCTION

are inhibited, causing the patient to abruptly cease volitional
movements in midstride (Heremans et al., 2013). This leads to an
increased fall risk, negatively impacts independence, and consequently decreases a patient’s overall quality of life. Therefore, the
development of therapies with the goal of reducing the impacts of
freezing episodes on gait is crucial to the well-being of the patients, their families, and society.
Biofeedback is the process of receiving information from the
body’s normal functions, often with the aid of external electronic
sensors. Auditory biofeedback utilizes sound for this purpose and
the use of auditory biofeedback has demonstrated the ability to
improve weight-bearing symmetry during gait for individuals
with lower limb injuries (Isakov, 2007). Similarly, use of combined somatosensory and audio-biofeedback for patients following
a stroke has demonstrated the potential to improve step length,
symmetry and speed significantly more than gait training with-

Parkinson disease is defined as a progressive neuromuscular disorder that interferes with motor pathways within the central nervous system (Kalia and Lang, 2015). Parkinson disease is the second most common degenerative disease of the central nervous system affecting 1% of the population above 60 years of age; it is
predicted to increase in prevalence as the population ages (Beitz,
2014; Tysnes and Storstein, 2017). Common clinical findings of
Parkinson disease include tremors, rigidity, ceasing (or “freezing”)
of volitional movements, hypokinesia, bradykinesia, decreased
stability limits, and a festinating gait pattern classified by abnormally slow shuffling steps with an anteriorly displaced center of
mass (Massano and Bhatia, 2012). The “freezing of gait” phenomenon is a particularly debilitating component of Parkinson disease
in which the voluntary muscle movements used to walk normally
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out augmented feedback (Sungkarat et al., 2011). There is limited
high-quality evidence supporting the use of rhythmic auditory
cues to enhance walking speed for patients with Parkinson’s disease (Lim et al., 2005). Furthermore, it is unclear if the positive
effects identified in the laboratory can subsequently lead to improved activities of daily living and a reduction of falls in the
community (Lim et al., 2005). In addition, the sustainability of a
cueing training program remains uncertain. More recently, Mirelman et al. (2011) conducted a pilot study with seven patients
with Parkinson disease utilizing an auditory biofeedback system
in which the device was worn on the patient’s belt and attached to
headphones by which the patient hears the auditory feedback.
These researchers concluded that audio-biofeedback training was
feasible and associated with improvements in balance for patients
with Parkinson disease (Mirelman et al., 2011); however, research
examining the utility of audio-biofeedback specific to gait training in this population is still quite limited (Gordt et al., 2018).
Thus, there appears to be a need for further efforts in the area of
rhythmic auditory cueing and its influence on gait and function
in patients with Parkinson disease.
A recent device that was developed called Electroskip (Electroskip LLC, Buffalo, NY, USA) produces real-time auditory biofeedback and a self-generated, trailing metronomic sound for the
purpose of cueing a patient with Parkinson disease. The hardware
itself is comprised of a wireless, wearable device that sends a discrete signal when the user steps on either the heel or toe force sensors. Electroskip is compatible with the musical instrument digital interface protocol allowing for a wide range of digital sounds,
synthesizers or musical beats to be utilized. The metronome
sound produced by the patient also adjusts in tempo-based upon
the speed of the walker. This is significant as Electroskip not only
generates instantaneous biofeedback, but also will serve as its own
auditory cue for the following steps in the maintained time frame,
which we hypothesize will address the gait speed abnormalities
associated with the freezing of gait phenomenon of Parkinson disease. Therefore, the purpose of this case study was to explore the
possible beneficial effects of a rehabilitation program with an audio-biofeedback technology called Electroskip in a patient with
moderate Parkinson disease.

MATERIALS AND METHODS
Participant
The patient was a 61-year-old man with moderate Parkinson
disease (Hoehn and Yahr Parkinson’s scale stage III) (Hoehn and
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Yahr, 1967) who had progressive episodes of freezing of gait. In
addition to Parkinson disease, which was diagnosed 3 years prior,
his medical history included dementia, depression, and hypertension. The patient’s Parkinson disease was managed with carbidopa-levodopa 4 times daily. The patient was also taking donepezil
hydrochloride for dementia, citalopram hydrobromide for depression, and hydrochlorothiazide for hypertension. In addition to
progressive episodes of freezing gait, the patient had a history of
greater than 3 falls per every 6 months span, decreased sitting and
standing balance without support, decreased upper and lower extremity strength, poor motor control and muscle sequencing, decreased upper extremity range of motion, and difficulty with dynamic balance and gait activities. While the patient also had verbal and cognitive deficits, he was alert, oriented to person and
place, and he was able to follow commands necessary during rehabilitation to be an active participant in his therapy. He was accompanied by his daughter, father, and cousin, who gave written
consent for participation in this case report and provided subjective information on his behalf. The patient lived with his elderly
father on the first floor of a multiple story home. Family safety
concerns included transferring to and from sitting to standing,
transferring in and out of a vehicle, reaching overhead, stepping
up/down from a curb, and safety during ambulation both indoors
and outside.
Outcome measures
The outcome measures for gait and balance included the Timed
Up and Go (TUG) test (Stegemöller et al., 2014), the modified
Gait Abnormality Rating Scale (mGARS) (VanSwearingen et al.,
1996), the modified Parkinson’s Activity Scale (mPAS) (Keus et
al., 2009), the Freezing of Gait Questionnaire (FOGQ) (Giladi et
al., 2000), and the Berg Balance Scale (BBS) (Berg et al., 1995).
These were selected as outcome measures based on their use in
prior studies with either elderly patients (mGARS, BBS) (Berg et
al., 1995; VanSwearingen et al., 1996) or with patients with Parkinson disease (TUG, mPAS, FOGQ, BBS) (Giladi et al., 2000;
Keus et al., 2009; Stegemöller et al., 2014). Medication dose and
timing remained constant over the course of treatment and outcome measures were consistently obtained at the same time of day
during the on phase of medication.
The TUG test is a timed trial assessing the time it takes for an
individual to rise from a chair, traverse a 3-m distance, and return.
This test was administered on testing day 1 and at the end of 6
weeks. The patient’s timed averages were collected from 5 trials
each under three conditions; shoes on but sound off, shoes on with
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Electroskip audio-biofeedback, and shoes on with Electroskip audio-biofeedback plus an accompanying background musical track.
Rest was given as needed to the patient and full recovery was ensured prior to proceeding to the next test trial. The order of the
testing conditions was random on day 1 and at week 6. Every trial
throughout the study began with the physical therapist positioning the patient in optimal sitting posture with consistent verbal
directions for completion of the TUG task.
The mGARS and mPAS were administered at three points
during the course of care: day 1, week 3, and week 6. The mGARS
is a physical therapist scored tool in which lower scores reflect a
more normalized gait pattern through observation of a 15.2-m
walk and graded on certain criteria such as heel contact and variability of movements (VanSweringen et al., 1996). The mPAS
(gait akinesia section specifically) is a physical therapist scored assessment in which the patient must stand up, walk a 3-m U-shaped
pattern, and return to sitting under 3 conditions (i.e., without extra task, with dual task, with cognitive task), in which higher
scores correspond with improved performance (Keus et al., 2009).
Two trials, with and without the Electroskip audio-biofeedback,
were performed at each testing trial. The order of testing was reversed at week 3 to limit effects of fatigue and learning. Both tools
were scored by the lead author and then reviewed by the patient’s
caregivers to ensure accuracy and to minimize bias. The mPAS
was not used in full, but limited to the section pertaining to gait
akinesia as the other sections were not relevant to this case.
The FOGQ is a 6-question survey reflecting how freezing episodes impact a person’s gait and daily activities, in which lower
scores are optimal (Giladi et al., 2000). The FOGQ, appendix B
specifically, showed a strong correlation between scores achieved
and quality of life amongst patients with Parkinson disease (Ellis
et al., 2011). The FOGQ was given to the patients’ caregivers to
complete due to the patient’s cognitive function. The question-

naire was completed on day 1, week 3, and week 6, with instructions to complete the form twice, reflecting on gait behaviors observed both with and without the Electroskip technology active
during the sessions.
The BBS is a commonly used functional balance assessment
tool designed to identify fall risk in community-dwelling older
adults (Berg et al., 1995). It is considered the reference standard,
and its use as a functional balance tool for individuals with neurologic conditions, including patients with Parkinson disease, has
been well documented (Qutubuddin et al., 2005; Taghizadeh et
al., 2018).

Fig. 1. Electroskip technology attachment to shoes.

Fig. 2. Electroskip sensor positioning under toes and heel.
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Intervention
The patient was scheduled for 3 physical therapy visits per week
for 6 weeks in addition to 3 additional testing days on day 1, week
3, and again at week 6. This visit schedule is consistent with Mirelman et al. (2011), who assessed the effects of an auditory biofeedback system to augment an individualized training program
on balance in patients with Parkinson disease. Physical therapy
visits were 45 min and consisted of upper extremity and trunk
stretching, followed by upper extremity and trunk strengthening,
and concluded with functional task training (e.g., step-ups, sit-tostand transfers, standing, kicking) and gait training (forward, backward, side stepping, turning, dual task [counting], step length
cueing, arm swing normalization). Gait training utilized Electroskip
technology, which is a wireless, wearable device that sends a discrete real-time generative audio-biofeedback signal when the user
steps on either the heel or toe force sensors positioned under the
innersoles (Fig. 1). Additionally, a self-generated metronomic sound
adjusts in tempo-based upon the speed of the walker, serving as
an auditory cue. The device is used by attaching two pressure sensors underneath the innersoles of the patient’s shoes (Fig. 2). A
transmitter attached to the shoelaces sent wireless pulses from the
sensors to a computer with audio software in order to convert the
signals into audio. The biofeedback sounds were in harmony with
three of the patient’s favorite songs, and the background music
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RESULTS
The patient completed 17 of the 18 scheduled training sessions
and all testing sessions; high satisfaction levels were reported by
the patient and family after completion of the 6-week rehabilitation program. No adverse events occurred during the rehabilitation program and no falls were reported outside of the clinic by
the patient or his caregivers. On day 1, the TUG test improved
from 53 sec to 39 sec with the use of Electroskip technology. At 6
weeks, the TUG test was 24 sec and 23 sec with and without the
use of Electroskip technology, respectively. The scores on the
TUG test with the use of Electroskip technology with background music were slightly longer than with the use of Electroskip technology alone (Fig. 3). For the mGARS, scores on day

1 were 3.5/21 with the Electroskip technology and 5.5/21 without the Electroskip technology. Scores under both conditions improved to 2/21 by week 6 (Fig. 4). For the mPAS, the score was
19 on day 1, 23 at 3 weeks and 21.5 at 6 weeks without Electroskip technology; with the use of Electroskip technology, the
mPAS increased to 23 on day 1 and at 3 weeks, and 23.5 at 6
weeks (Fig. 5). For the FOGQ, the score without the Electroskip
technology was 14 on day 1 and it remained at 14 at weeks 3 and
6; with the use of Electroskip technology, the FOGQ decreased to
6 at weeks 3 and 6 (Fig. 6). The BBS improved from 39 days 1 to
48.5 at week 6, however, Electroskip technology was not used
during assessment with the BBS.
6
5

mGARs score

was included as an optional feature. When the patient would perform typical functional training, Electroskip would produce the
selected tonal patterns in a steady, trailing metronomic fashion.
The patient was asked to place emphasis on fluid motions that
would produce a continuous and rhythmic audio-biofeedback response. The background music tracks would be used as seen fit by
the therapist in order to encourage initiation of movement and
participation.
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Fig. 4. The patient’s modified Gait Abnormality Rating Scale (mGARs) scores
comparing weeks 1, 3, and 6 with and without the use of Electroskip technology.

15
10

6
Week

Fig. 3. The patient’s mean Timed Up and Go test results comparing week 1 to
week 6. The “no sound” condition refers to test performance without the use
of Electroskip technology or background music. The “just skips” condition refers to test performance with the use of Electroskip technology and no background music. The “music and skips” condition refers to test performance with
the use of Electroskip technology and background music. The vertical lines in
the middle in each column represent the range of scores for each test trial.
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Fig. 5. The patient’s modified Parkinson’s Activity Scale (mPAS) scores comparing weeks 1, 3, and 6 with and without the use of Electroskip technology.
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Fig. 6. The patient’s the Freezing of Gait Questionnaire (FOGQ) scores comparing weeks 1, 3, and 6 with and without the use of Electroskip technology.

DISCUSSION
The purpose of this case study was to explore the possible beneficial effects of a rehabilitation program with an audio-biofeedback technology (e.g., Electroskip) in a patient with moderate
Parkinson disease. For the patient described in this case report, we
hypothesized that Electroskip technology would address the gait
speed abnormalities associated with the freezing of gait phenomenon of Parkinson disease.
This hypothesis was based upon the limited reports that have
described some usefulness of audio-biofeedback with gait training
in patients with Parkinson disease (Gordt et al., 2018; Lim et al.,
2005; Thaut et al., 1996). Thaut et al. (1996) evaluated the effect
of rhythmic auditory stimulation on various aspects of gait following a 3-week home-based gait-training program for patients with
Parkinson disease. Patients who participated in the gait-training
program with rhythmic auditory stimulation significantly improved their gait velocity by 25%, stride length by 12%, and step
cadence by 10% more than patients who participated in a selfpaced gait-training program not supplemented with rhythmic
auditory stimulation, whose gait velocity improved by 7%, and
patients who did not participate in a gait-training program,
whose gait velocity decreased by 7%. Additionally, some features
of the gait cycle as profiled with electromyography changed toward more normal muscle activation patterns for those patients
who participated in the gait-training program with rhythmic auditory stimulation (Thaut et al., 1996). In our case, we did not
formally assess gait parameters such as velocity, stride length, or
step cadence or electromyographic activity during gait. Nonethe692
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less, after 6 weeks of training with Electroskip technology, which
combines rhythmic auditory stimulation with audio-feedback,
our results seem to reflect those of Thaut et al. (1996), as improvements were observed across all testing conditions (with and without the technology active) in the majority of outcome measures
used that dealt with gait. Thus, our hypothesis was generally supported.
High-quality evidence on the effects of external rhythmical
cueing on gait in patients with Parkinson disease is limited. Furthermore, it is unclear whether the limited positive effects identified in the laboratory can be generalized to clinical rehabilitation
programs with subsequent improved activities of daily living and
reduced frequency of falls in the community (Lim et al., 2005).
However, the results of this case report suggest potential immediate and short term (i.e., 6 weeks) positive therapeutic effects from
the use of the Electroskip audio-biofeedback technology. While
the patient described in this case report had verbal and cognitive
deficits, he was alert, oriented to person and place, and he was able
to follow commands necessary during rehabilitation to be an active participant in his therapy. The patient in this report subsequently performed better in every outcome during measurements
taken on the first day while the technology was in use, suggesting
that the patient’s motor skills received an immediate benefit from
the cueing and biofeedback generated by the metronome-like
sound of the Electroskip. After 6 weeks of participation in a rehabilitation program augmented with Electroskip technology, improvements were observed across all testing conditions in the majority of outcome measures used; this was most notable in the
TUG test and mGAR scores (Figs. 3 and 4). This implies that the
Electroskip technology may also have some benefit when used in
a clinical setting for achievement of long-term rehabilitation
goals. Electroskip technology, therefore, may offer a potential
combination of immediate and short term (i.e., 6 weeks) clinical
benefits that warrant further research into the treatment of motor
impairments in patients with Parkinson disease.
For the mPAS scores, there was slightly improved performance
noted with the Electroskip technology turned on in both weeks 1
and 6 (Fig. 5) compared to when the Electroskip technology was
turned off. At week 3, however, the scores did not differ between
those same conditions. Scores achieved without the use of the
Electroskip technology increased from week 1 to 3, and then
slightly decreased at week 6. Scores achieved with the Electroskip
technology active showed little variation, however; they were always the same or superior when compared to the scores seen without non-Electroskip technology. The condition of the mPAS in
https://doi.org/10.12965/jer.1938374.187
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which improvement was most notable when the Electroskip technology was enabled was when the patient was asked to perform a
dual cognitive counting task while navigating the 3-m U-shaped
pattern. The audio-feedback associated with the device appeared
to decrease the cognitive demands on the pacing of the motor
component of this task, thus allowing for the counting task to be
performed with greater ease. Additionally, given the results from
the other outcome measures, Electroskip technology enhanced the
patient’s ability to perform smooth, voluntary motions with an
immediate increase in ambulation and turning speed; the 6-week
training program produced further improvements observable under all conditions.
The BBS scores from before and after the 6-week data collection
period were included as supplemental data to further evaluate the
Electroskip technology. Within the month prior to beginning
data collection, the patient scored a 39 with their prior physical
therapy program. This score increased to 48.5 after 8 weeks,
which encompassed the entire 6-week duration of this study. Our
results with respect to improvements in the BBS are generally
consistent with those of Mirelman et al. (2011), who reported significant improvements in the BBS following a 6-week individualized training program that was augmented with auditory biofeedback in 7 patients with Parkinson disease. More specifically, Mirelman et al. (2011) reported positive trends in all measures of balance control in response to the training when subjects were assessed after the conclusion of the 6-week program. The BBS significantly improved by 3% (P =0.032) (mean pretraining
score=49.0 ± 7.2; mean posttraining score=50.4 ± 6.7) and although not statistically significant, the TUG test scores and time
to perform 5 sit-to-stand maneuvers improved by 11% (P=0.07)
and 7.3% (P=0.09), respectively. These results suggest that overall balance performance may be improved following an individualized training program that has been augmented with auditory
biofeedback in patients with Parkinson disease. Future trials with
the Electroskip technology, or other forms of auditory biofeedback, should continue to include the BBS as a formal performance
measure for more conclusive findings.
Previous research has demonstrated that visual, vibratory and
auditory cueing can be effective means of overcoming a freezing
episode (Velik, 2012). Cues that are both continuous and relevant
to the action of stepping, such as those produced by the Electroskip, have also been found to delay the onset of freezing by engaging sensorimotor circuitry and bypassing the basal ganglia
(Young et al., 2016). The potential to use auditory cues for more
lasting improvements was investigated by Plotnik et al. (2014),
https://doi.org/10.12965/jer.1938374.187

who trained individuals with Parkinson disease to respond to
rhythmic auditory stimulation immediately prior to stimuli
known to trigger freezing episodes and demonstrated reduced episodes of freezing, improved gait speed and performance even
when cues were removed. While this type of motor learning
training may be beneficial, it requires extensive set-up of the environment to produce triggered stimulation. By combining this
type of auditory stimulation with audio-biofeedback and translating this intervention into a wearable technology, the Electroskip
was able to yield similar reductions in freezing episodes while
wearing a device that was highly portable and worked flexibly
within the clinic environment. Improvements in freezing, in this
case, were not found to persist when the device was turned off as
they did in previous investigations; however, it is likely the subject’s cognitive involvement limited his potential for motor learning. The subject did demonstrate improvements in gait speed on
the TUG test over the course of treatment using the Electroskip
that persisted when the device was removed. Walking with rhythmic auditory cueing has been previously found to improve gait
cadence, velocity and stride length (Spaulding et al., 2013) and
the results of this case study indicate that repeated training with
audio-biofeedback during gait may have a similar beneficial training effect that can carry over to uncued gait.
There are some limitations to this report that should be considered. First, because this was a single subject case report, cause and
effect cannot be inferred and the conclusions that can be drawn are
limited. Observable benefits may not be generalizable to other patient populations. Second, considerable care was taken to develop
the testing protocol in an individual with freezing episodes and
great variability in gait. However, we are not completely sure of
the effect of fatigue and motor learning on our testing protocol.
Furthermore, placebo response rates may be high for patients with
Parkinson disease (Diederich and Goetz, 2008). Subsequent trials
are needed to determine optimal testing strategies that control for
fatigue and motor learning factors, as well as possible placebo effects. However, a case series or a small open-label trial would have
clinical merit and could serve as the next logical step for investigating the effects of Electroskip technology. Third, the patient
had limited verbal and writing/reading comprehension skills,
which likely interfered with a true self-assessment on the FOGQ.
For this reason, the patient’s caregivers completed the instrument
to the best of their ability and in agreement with one another.
This strategy may not be optimal to assess true gait improvements, especially when they were asked to reflect on gait behaviors observed with the Electroskip technology active during the
http://www.e-jer.org
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sessions, as the FOGQ is typically completed based of freezing behavior in past week. Additionally, the Electroskip technology was
unavailable to the patient at home, so any comparisons of the patient’s gait with and without the technology on had to be done at
similar times of the day and under similar circumstances to ensure
accuracy and thus, may not reflect home use performance or the
influence of the technology on activities of daily living.
In conclusion, the results of this case report suggest that a rehabilitation program focused on functional tasks, balance, and gait
training using the Electroskip technology may be beneficial for
improving gait and balance in a patient with moderate Parkinson
disease. Future work is needed to determine the effectiveness of
Electroskip technology by means of randomized controlled trials.
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